Heart Diseases
Heart Diseases
Search
Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
The Research Process
The Research Process
Science & Innovation
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Our FOCUS
Our FOCUS
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
We are there for our patients – even in crisis regions.
We are there for our patients – even in crisis regions.
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
Boehringer Ingelheim Awards Innovation Prize to Ablevia
Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system
Dog parasites: What you should know
Dog parasites: What you should know
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Immune cell directed therapies
Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.
Interstitial Lung Diseases - Sound the ILD Alarm
Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment.
Fighting Foot and Mouth Disease
Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals such as cattle, pigs, sheep, and goats. Boehringer Ingelheim France is cooperating with its Kazakh partner QazBioPharm to manufacture vaccines.
75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria
Veterinarians go above and (far) beyond.
Veterinarians go above and (far) beyond.
Living and Working in Times of War - Employees from Ukraine Report
Living and Working in Times of War - Employees from Ukraine Report
Who we are
The Boehringer Ingelheim Regional Center Vienna (RCV for short) bears business responsibility for more than 30 countries in Central and Eastern Europe and Central Asia.
Code of Conduct
Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Patients in Focus
Boehringer Ingelheim RCV provides over six million patients with innovative therapies. Ensuring that the patients’ needs at every stage are met precisely is of decisive importance.
Drug discovery Boehringer Ingelheim
Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.
Our Expectations
We are committed to exemplary ethical and professional conduct both within the company and from our suppliers.